Regulatory & Legal

The acquisition of Canadian digital asset pioneer 3iQ by Coincheck Group solidifies a global powerhouse, signaling a new era of institutional crypto consolidation.

As SAB Biotherapeutics prepares for key investor talks, a closer look reveals its novel T1D therapy and the unique bovine tech aiming to change treatment.

Cuentas and Hallo 015 launch a unique MVNO service, blending mobile connectivity and exclusive content for the growing Israeli community in the United States.

A new study aims to confirm a novel immunotherapy's dramatic results in colorectal cancer, offering hope for patients with limited treatment options.

A new partnership highlights how specialized tech is becoming essential for navigating complex IRA tax rules, de-risking billions in renewable energy projects.

Diga-Talk Solutions names John K. Sullivan its new CBO, leveraging his 30 years in fire service to revolutionize mission-critical communications.

Texas's largest housing authority marks 10 years of flawless financial audits while launching major housing projects and navigating community challenges.

Over 200 Wasilla school bus drivers are on strike, disrupting transport for 18,000 students amid a bitter dispute over wages, safety, and alleged unfair labor practices.

Lantheus gains FDA tentative approval for a LUTATHERA rival, signaling new hope for rare cancer patients and a legal battle with Novartis over market access.

Ag Growth International brings back its 23-year former CFO to the board, signaling a major push for operational excellence amid financial pressures.

NVIDIA invests billions in optics leader Coherent to secure the high-speed, US-made components needed to power the next generation of AI factories.

A new supplement, backed by a gold-standard clinical trial, promises the metabolic and appetite-curbing benefits of fasting without any dietary changes.

For millions suffering from relentless chronic cough with no approved treatments, Trevi Therapeutics' Haduvio offers a new possibility backed by strong clinical data.

Fresh off a major clinical trial victory, Alumis Inc. heads to a key investor conference. What's next for its promising pipeline and soaring stock?

Donors granted a record $3.9 billion via Vanguard Charitable in 2025, highlighting the growing power and agility of donor-advised funds in philanthropy.

Amid consumer complaints of bait-and-switch pricing, U-Haul introduces a price guarantee, challenging competitors and signaling a shift in the market.

As Middle East conflict roiled markets, 24/7 on-chain gold offered an immediate safe haven, challenging the dominance of traditional financial systems.

With major trials underway for its cancer and vision drugs, NovaBridge's upcoming investor presentation could be a pivotal moment for the biotech firm.

Zoetis is acquiring Neogen's genomics unit for $160M, a strategic move set to accelerate data-driven innovation in livestock and companion animal care.

The healthcare firm reports a 56% revenue surge to $3.2B, but a "material weakness" in financial controls and a delayed SEC filing cast a shadow.